Press Release Immuneering Comments on Today’s FDA Approval in Second-Line Metastatic Pancreatic Cancer, Reiterates Focus on First-Line Patients Aug 26
Press Release Immuneering Reports Second Quarter 2026 Financial Results and Provides Business Updates Aug 5